Spirometric Evaluation of Respiratory Function in Vapers, Smokers, and Non-Smokers: A Cross-Sectional Study
Journal of Pharma and Biomedics · 27.10.2026 · 4 (4) · 479-478
DOI: 10.56810/jpbm.004.04.0305 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Pharma and Biomedics, online erschienen am 27.10.2026. Verfasst von Rubab Andleeb und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The increasing use of vape has raised concerns regarding their potential effects on respiratory health, particularly among the young adults. Conventional cigarette smoking is an established risk factor for pulmonary dysfunction, while the comparative effects of vaping on large and small airway function are still being investigating.
Objective
To evaluate and compare spirometric parameters and patterns of ventilatory impairment among vapers, conventional cigarette smokers, and non-smokers. Materials and methods: An analytical cross-sectional study was conducted among 111 male participants aged 18–40 years, equally distributed into three groups: vapers (n = 37), smokers (n = 37), and non-smokers (n = 37). Spirometry was performed using a calibrated spirometer in accordance with American Thoracic Society/European Respiratory Society guidelines. Parameters assessed included forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio, forced expiratory flow between 25% and 75% of FVC (FEF25-75), peak expiratory flow rate (PEFR), and estimated lung age.
Results
There are a statistically significant differences were noted among the three groups in FVC (p = 0.037), FEV1 (p < 0.001), FEV1/FVC ratio (p < 0.001), FEF25-75 (p < 0.001), and estimated lung age (p < 0.001). Among the Vapers there was the lowest mean FEF25-75 (3.03 ± 0.29 L/s), compared with smokers (3.44 ± 1.15 L/s) and non-smokers (4.15 ± 0.76 L/s), suggesting possible small-airway functional impairment. Among the vapers, mean estimated lung age was higher (41.03 ± 14.24 years) than smokers (39.38 ± 12.83 years) and non-smokers (27.92 ± 6.75 years). PEFR did not differ significantly among the groups (p = 0.065). Respiratory symptoms, mainly cough and shortness of breath were also reported more among vapers.
Conclusion
There is a significant difference in pulmonary function among vapers, smokers, and non-smokers as vapers exhibiting significant low small-airway flow and higher estimated lung age. These findings suggest that vaping may be associated with early alterations in respiratory function even among relatively young adults.
Zitieren
APA
Andleeb, R., Muzammil, D. H. S., Rafique, D. F., Mehmood, S., Shahid, Z., & Butt, G. U. (2026). Spirometric Evaluation of Respiratory Function in Vapers, Smokers, and Non-Smokers: A Cross-Sectional Study. Journal of Pharma and Biomedics, 4(4), 479-478. https://doi.org/10.56810/jpbm.004.04.0305
Vancouver
Andleeb R, Muzammil DHS, Rafique DF, Mehmood S, Shahid Z, Butt GU. Spirometric Evaluation of Respiratory Function in Vapers, Smokers, and Non-Smokers: A Cross-Sectional Study. Journal of Pharma and Biomedics. 2026;4(4):479-478. doi:10.56810/jpbm.004.04.0305
BibTeX
@article{Andleeb2026,
author = {Andleeb, Rubab and Muzammil, Dr. Hafiz Shahzad and Rafique, Dr Faisal and Mehmood, Shoaib and Shahid, Zuhaa and Butt, Guzel Umar},
title = {Spirometric Evaluation of Respiratory Function in Vapers, Smokers, and Non-Smokers: A Cross-Sectional Study},
journal = {Journal of Pharma and Biomedics},
year = {2026},
volume = {4},
number = {4},
pages = {479--478},
doi = {10.56810/jpbm.004.04.0305}
}
EUVIMED